Peptide Therapy Stacks: Combining Peptides for Maximum Results

Individual peptides produce real, measurable results. But the most significant outcomes in peptide therapy come from combining peptides that target complementary biological pathways — creating synergistic effects that exceed what any single peptide achieves alone. This is the concept behind peptide stacking, and it is the foundation of how we design protocols at Rewind Anti-Aging Miami.

The principle is straightforward: your body does not age, recover, or perform through a single mechanism. Fat loss involves hormonal signaling, metabolic regulation, and mitochondrial function simultaneously. Recovery requires tissue repair, inflammation control, and growth factor activation working together. Aging involves DNA damage, mitochondrial decline, hormonal shifts, and cellular senescence all at once.

A well-designed peptide stack addresses these interconnected systems together rather than one at a time. The result is compounding benefits — each peptide enhances the effectiveness of the others.

This guide covers the five most common peptide stacks we prescribe at Rewind, who each is designed for, what to expect, and why medical supervision makes the difference between mediocre results and transformational ones.

Why Peptides Work Better Together

Before diving into specific stacks, it helps to understand why combination therapy outperforms individual peptides.

Complementary mechanisms. Different peptides act on different receptors, pathways, and biological systems. CJC-1295 stimulates growth hormone-releasing hormone (GHRH) signaling, while ipamorelin activates ghrelin receptors. Together, they stimulate GH release through two independent pathways simultaneously, producing a stronger and more physiologic pulse than either achieves alone.

Amplification effects. Some peptides create biochemical conditions that make other peptides more effective. For example, growth hormone optimization improves tissue perfusion and nutrient delivery, which enhances the tissue-repair effects of BPC-157. The healing peptide works better when the hormonal environment supports its mechanism.

Broader coverage. A single peptide addresses one or two aspects of a complex goal. A stack addresses multiple aspects simultaneously. If your goal is body recomposition, a stack targeting both visceral fat metabolism and hormonal optimization will produce faster, more complete results than either approach alone.

Reduced individual dosing. When two peptides work synergistically, each can often be used at lower doses than would be required if used independently. This can reduce side effects while maintaining or improving efficacy — a principle well-established in pharmacology.

Stack 1: GH Optimization — CJC-1295 + Ipamorelin

The Most Popular Starter Stack

The CJC-1295 and ipamorelin combination is the single most prescribed peptide stack in anti-aging medicine, and for good reason. It is effective, well-tolerated, extensively studied, and produces broad-spectrum improvements that benefit nearly every patient profile.

How It Works

CJC-1295 is a growth hormone-releasing hormone (GHRH) analog that stimulates the pituitary gland to produce and release growth hormone. It extends the half-life of your natural GHRH signaling, creating a sustained elevation in GH pulsatility rather than a single spike.

Ipamorelin is a selective growth hormone secretagogue that activates the ghrelin receptor (GHS-R) in the pituitary. Unlike older secretagogues, ipamorelin is highly selective — it stimulates GH release without significantly affecting cortisol, prolactin, or appetite.

When combined, these two peptides stimulate GH release through complementary pathways: CJC-1295 amplifies the GHRH signal while ipamorelin provides an additional stimulus through the ghrelin pathway. Research published by Teichman et al. in the Journal of Clinical Endocrinology and Metabolism (2006) demonstrated that combined GHRH and GHS administration produces GH release that exceeds the sum of either agent alone — a true synergistic effect.

Who It Is For

• First-time peptide therapy patients looking for a proven, well-tolerated starting point
• Adults over 35 experiencing declining energy, poor sleep, slower recovery, or gradual body composition changes
• Patients who want to optimize growth hormone naturally without exogenous GH
• Athletes seeking improved recovery and training adaptation
• Anyone building a foundation before adding more targeted peptides

What to Expect

Weeks 1-2: Improved sleep quality is typically the first noticeable change. Patients report falling asleep faster, sleeping more deeply, and waking more refreshed.

Weeks 3-6: Energy levels stabilize and improve. Recovery from exercise accelerates. Skin quality may begin to improve with increased collagen production.

Weeks 8-12: Body composition changes become visible — gradual fat loss (particularly in the midsection) and improved muscle tone. Hair and nail growth may accelerate.

Months 3-6: Full optimization of the GH axis. Patients report sustained improvements in energy, body composition, recovery, cognitive function, and overall vitality.

Protocol Details

CJC-1295/ipamorelin is typically administered as a subcutaneous injection, most commonly before bed to align with your natural nocturnal GH pulse. Dosing is individualized based on your IGF-1 levels, body weight, and response. Most protocols run for 3 to 6 months, with periodic lab monitoring to track IGF-1 and metabolic markers.

Stack 2: Recovery — BPC-157 + TB-500

The Tissue Repair Powerhouse

If you are dealing with an injury, recovering from surgery, managing chronic inflammation, or simply want to heal faster from intense training, the BPC-157 and TB-500 combination is the most effective recovery stack available through peptide therapy.

How It Works

BPC-157 (Body Protection Compound-157) is a gastric pentadecapeptide that promotes tissue healing through multiple mechanisms: upregulation of growth factor signaling (VEGF, FGF), promotion of angiogenesis (new blood vessel formation), and activation of cellular repair pathways. Research has demonstrated its effectiveness across tendons, ligaments, muscle, bone, and gut tissue. It also has significant anti-inflammatory properties and supports gut mucosal integrity.

TB-500 (Thymosin Beta-4) is a naturally occurring peptide involved in cell migration, tissue remodeling, and wound healing. It reduces inflammation systemically, promotes new blood vessel growth, and supports the repair of damaged tissue throughout the body. Where BPC-157 tends to act more locally at the site of injury, TB-500 provides broader systemic healing support.

Together, they create a comprehensive repair environment: BPC-157 drives localized tissue regeneration and growth factor activation while TB-500 provides systemic anti-inflammatory and tissue-remodeling support. The two mechanisms complement each other, accelerating healing timelines that would be longer with either peptide alone.

Who It Is For

• Athletes recovering from tendon, ligament, or muscle injuries
• Post-surgical patients seeking accelerated healing (with physician approval)
• Patients with chronic joint pain, tendinopathy, or repetitive strain injuries
• Individuals with gut health issues — BPC-157 specifically supports intestinal mucosal healing
• Active adults who want to reduce recovery time between training sessions
• Patients with chronic inflammatory conditions seeking systemic inflammation reduction

What to Expect

Week 1-2: Reduction in acute pain and inflammation at injury sites. Improved gut comfort in patients with GI issues.

Weeks 3-6: Noticeable improvement in range of motion, reduced swelling, and accelerated tissue repair. Many patients report that nagging injuries that have persisted for months begin to resolve.

Weeks 6-12: Substantial healing progress. Patients returning to activities they had been avoiding due to pain or limited function. Gut healing patients often report significant symptom improvement.

Protocol Details

BPC-157 and TB-500 are administered via subcutaneous injection, typically on a daily or alternating-day schedule depending on the severity of the condition. Some providers recommend injecting BPC-157 near the site of injury for localized effect, while TB-500 is injected subcutaneously in the abdominal area for systemic distribution. Protocols typically run for 4 to 12 weeks, with extension as needed based on clinical response.

Stack 3: Body Recomposition — Tesamorelin + MOTS-c

Visceral Fat Reduction Meets Metabolic Optimization

For patients whose primary goal is transforming body composition — reducing visceral fat, improving metabolic efficiency, and building a leaner physique — the tesamorelin and MOTS-c combination targets the two most important pathways: hormonal fat metabolism and mitochondrial energy regulation.

How It Works

Tesamorelin is an FDA-approved GHRH analog that has been demonstrated in randomized controlled trials to significantly reduce visceral adipose tissue (the metabolically dangerous fat that accumulates around your organs). It stimulates GH release, which in turn promotes lipolysis — the breakdown of stored fat for energy. Unlike exogenous GH, tesamorelin works through your body’s own pituitary gland, maintaining physiologic GH pulsatility.

MOTS-c is a mitochondrial-derived peptide that acts as a metabolic regulator. It activates AMPK signaling (the same pathway activated by exercise and caloric restriction), improves insulin sensitivity, enhances glucose uptake by muscle tissue, and supports mitochondrial biogenesis. In essence, MOTS-c optimizes the cellular machinery that determines how efficiently your body burns fuel.

When stacked, tesamorelin drives fat mobilization through the GH pathway while MOTS-c optimizes mitochondrial function and metabolic efficiency. The fat being released by tesamorelin is more effectively burned for energy because MOTS-c has improved the metabolic machinery responsible for fat oxidation. This dual-pathway approach produces body composition changes that are faster and more complete than either peptide achieves independently.

Who It Is For

• Patients with stubborn visceral fat that resists diet and exercise
• Men and women experiencing metabolic slowdown associated with aging
• Patients with insulin resistance or metabolic syndrome who want to improve metabolic markers
• Anyone seeking meaningful body recomposition — not just weight loss, but shifting the ratio of fat to lean mass
• Patients who have plateaued on a weight loss program and need a metabolic reset

What to Expect

Weeks 1-4: Improved energy and exercise tolerance as mitochondrial function improves. Early metabolic changes may be reflected in lab work before they are visible in the mirror.

Weeks 4-8: Waist circumference begins to decrease as visceral fat reduces. Improved insulin sensitivity becomes measurable on labs. Patients often report a shift in how their body responds to food and exercise.

Weeks 8-16: Significant body composition changes become visible. Reduction in visceral fat, improved muscle definition, and better overall metabolic efficiency. Lab markers (fasting glucose, insulin, lipid panel) typically show meaningful improvement.

Protocol Details

Tesamorelin is administered as a daily subcutaneous injection, typically in the abdominal area. MOTS-c is administered subcutaneously, often on a 3 to 5 times per week schedule. Protocols generally run for 12 to 26 weeks, with metabolic labs monitored at baseline, 8 weeks, and periodically thereafter. This stack pairs well with structured nutrition and exercise programs for maximum effect.

Stack 4: Longevity — Sermorelin + MOTS-c + NAD+

The Comprehensive Anti-Aging Protocol

For patients focused on slowing biological aging at the cellular level, this three-component stack addresses the major pillars of longevity: growth hormone optimization, mitochondrial function, and cellular repair. It is the most comprehensive anti-aging peptide protocol we offer.

How It Works

Sermorelin is a GHRH analog that stimulates natural growth hormone production from the pituitary. GH levels decline approximately 14% per decade after age 30, and this decline contributes to loss of lean mass, increased body fat, reduced bone density, impaired recovery, and diminished skin quality. Sermorelin restores youthful GH pulsatility without the risks associated with exogenous GH administration.

MOTS-c optimizes mitochondrial function and metabolic efficiency through AMPK activation, improved insulin sensitivity, and support for mitochondrial biogenesis. Mitochondrial dysfunction is recognized as one of the primary hallmarks of biological aging, and MOTS-c directly addresses this mechanism.

NAD+ therapy restores the cellular fuel supply that powers DNA repair (via PARP enzymes), sirtuin activation (the longevity gene pathway), and mitochondrial energy production. NAD+ levels decline by roughly 50% every 20 years, and this depletion is both a consequence and a driver of aging.

Together, these three interventions create a coordinated assault on the fundamental mechanisms of aging: sermorelin restores the hormonal signaling environment, MOTS-c optimizes the cellular energy machinery, and NAD+ provides the molecular fuel that DNA repair and longevity pathways require to function. Each component enhances the others — GH optimization improves tissue perfusion that enhances NAD+ delivery, while NAD+ fuels the sirtuin pathways that regulate how effectively cells respond to GH and metabolic signals.

Who It Is For

• Adults over 40 who are proactively focused on healthspan and longevity
• Patients who want to address aging at the cellular level rather than just managing symptoms
• Individuals interested in measurable anti-aging results (paired with TrueAge epigenetic testing to track biological age)
• Patients who have optimized the basics (sleep, nutrition, exercise) and want to add the next level of cellular support
• Those experiencing multiple signs of accelerated aging — fatigue, cognitive decline, slow recovery, metabolic dysfunction — simultaneously

What to Expect

Weeks 1-4: Improved sleep quality and energy (from sermorelin and NAD+). Enhanced mental clarity, particularly after NAD+ infusion. Better exercise tolerance.

Weeks 4-12: Progressive improvement in body composition, skin quality, recovery speed, and cognitive function. Patients often describe a cumulative effect — each week feels slightly better than the last.

Months 3-6: Full protocol optimization. Patients report feeling fundamentally different in their baseline energy, mental sharpness, physical resilience, and overall vitality. Objective markers (IGF-1, metabolic panels, and where tested, biological age) typically show measurable improvement.

Protocol Details

Sermorelin is administered as a nightly subcutaneous injection. MOTS-c is administered subcutaneously 3 to 5 times per week. NAD+ is delivered via IV infusion — typically a loading phase of 2 to 4 infusions over 1 to 2 weeks, followed by monthly maintenance sessions. This stack requires comprehensive baseline labs and periodic monitoring of IGF-1, metabolic markers, and NAD+-related biomarkers.

Stack 5: TRT Enhancement — Sermorelin + BPC-157 With Testosterone

Amplifying Testosterone Therapy Results

For men already on testosterone replacement therapy (or considering it), adding sermorelin and BPC-157 creates a protocol that amplifies TRT’s benefits across muscle growth, recovery, tissue repair, and overall performance. This stack is detailed further in our guide to peptides and testosterone stacking.

How It Works

Testosterone therapy restores the androgenic hormonal environment necessary for muscle protein synthesis, energy, libido, and metabolic health. However, TRT alone does not address the concurrent decline in growth hormone or the tissue-repair demands of active patients.

Sermorelin adds growth hormone optimization to the equation. GH and testosterone have well-documented additive effects on body composition — testosterone drives muscle protein synthesis through androgen receptor activation, while GH promotes lipolysis, collagen synthesis, and tissue repair through separate pathways. Research in the Journal of Clinical Endocrinology and Metabolism has demonstrated that combined GH and testosterone administration produces greater improvements in lean mass and fat reduction than either hormone alone.

BPC-157 provides targeted tissue-repair support that is particularly valuable for men on TRT who train intensely. TRT enhances your ability to train harder and recover hormonally, but the structural tissues — tendons, ligaments, joints, and gut — need their own support system. BPC-157 fills this gap by promoting tendon and ligament healing, reducing inflammation, and supporting gut mucosal integrity (relevant for patients on medications or supplements that may stress the GI tract).

Who It Is For

• Men currently on TRT who want to maximize their results
• Men over 40 experiencing both testosterone and GH decline
• Active men on TRT who train intensely and want faster structural tissue recovery
• Men on TRT who are dealing with joint pain, tendon issues, or chronic inflammation
• Patients who want a comprehensive hormone and recovery protocol rather than TRT in isolation

What to Expect

Weeks 1-4: Improved sleep (sermorelin), reduced joint or tendon pain (BPC-157), and enhanced recovery between training sessions. The GH component begins to complement TRT’s anabolic effects.

Weeks 4-8: Noticeable improvements in body composition beyond what TRT alone was producing. Increased training capacity. Resolution or significant improvement in nagging injuries or chronic pain.

Weeks 8-16: Full synergistic effect. Patients report a distinctly higher level of physical performance, faster recovery, better body composition, and improved overall quality of life compared to TRT alone. The combination effect becomes clearly apparent.

Protocol Details

Testosterone therapy continues per the patient’s established protocol. Sermorelin is added as a nightly subcutaneous injection. BPC-157 is administered subcutaneously daily, either systemically or near the site of specific injuries. Labs monitor testosterone, free T, estradiol, IGF-1, CBC, metabolic panel, and liver function at regular intervals.

Lab Work and Monitoring: Non-Negotiable

Every peptide stack at Rewind Anti-Aging Miami begins with and is guided by comprehensive lab work. This is not optional — it is the difference between guessing and knowing.

Baseline Labs Before Starting

• IGF-1 — Establishes your current growth hormone status and serves as the primary marker for monitoring GH-releasing peptide effectiveness
• Comprehensive metabolic panel — Assesses liver function, kidney function, and electrolyte balance
• Fasting glucose and insulin — Evaluates metabolic health and insulin sensitivity (critical for MOTS-c and tesamorelin monitoring)
• Lipid panel — Baseline cardiovascular metabolic markers
• Hormone panel — Total and free testosterone, estradiol, thyroid function (TSH, free T3, free T4), DHEA-S
• CBC with differential — Complete blood count to establish hematologic baseline
• Inflammatory markers — hsCRP, ESR where clinically indicated

Ongoing Monitoring

Labs are repeated at 6 to 8 weeks after protocol initiation, then quarterly during the first year of therapy. Your provider reviews results at each checkpoint and adjusts peptide selection, dosing, and cycling based on objective data combined with your subjective response.

This monitoring serves three purposes: confirming that your stack is producing the intended biochemical effects, ensuring safety by tracking organ function and metabolic markers, and providing the data needed to optimize your protocol over time.

How Stacks Are Adjusted Over Time

Peptide protocols are not static prescriptions. They are living plans that evolve based on your response, goals, and changing biology.

Initial optimization (months 1-3). During this phase, your provider establishes your therapeutic doses based on lab response and symptom improvement. Adjustments are common and expected — peptide therapy is precision medicine, not one-size-fits-all.

Cycling. Some peptides benefit from cycling — periods of use followed by planned breaks. GH-releasing peptides may be cycled to prevent receptor desensitization, while BPC-157 and TB-500 are typically used for defined treatment courses around specific healing goals.

Stack evolution. As your initial goals are met, your stack may evolve. A patient who starts with CJC-1295/ipamorelin for GH optimization may later add MOTS-c for metabolic support, or transition to a longevity-focused stack as their priorities shift from performance to healthspan.

Seasonal adjustments. Some patients adjust their stacks seasonally — emphasizing body composition peptides before summer, recovery peptides during heavy training blocks, and longevity peptides during lower-intensity periods.

Why Medical Supervision Is Essential

Peptides are powerful signaling molecules that influence hormonal, metabolic, and immune pathways. Using them without medical supervision introduces unnecessary risk.

Dosing precision. Your optimal dose depends on body weight, baseline hormone levels, metabolic status, and individual receptor sensitivity. Without lab-guided dosing, you are guessing with hormonal signaling molecules.

Quality assurance. The peptide market includes both pharmaceutical-grade and questionable-quality products. Medical providers source from licensed compounding pharmacies that adhere to USP standards, ensuring purity, potency, and sterility.

Monitoring for adverse effects. While peptides are generally well-tolerated, monitoring allows early detection of elevated IGF-1, insulin changes, liver enzyme shifts, or other markers that warrant protocol adjustment.

Drug interactions and safety. Peptides can interact with other medications and therapies. A qualified provider evaluates your complete medication profile before prescribing any protocol, and ensures compliance with applicable regulations.

At Rewind Anti-Aging Miami, every peptide therapy protocol begins with our comprehensive diagnostic process and is managed by licensed medical professionals with ongoing lab monitoring and clinical follow-up.

Choosing the Right Stack for Your Goals

Primary Goal	Recommended Stack	Key Peptides
General optimization and GH support	GH Optimization	CJC-1295 + Ipamorelin
Injury recovery and tissue repair	Recovery	BPC-157 + TB-500
Fat loss and metabolic improvement	Body Recomp	Tesamorelin + MOTS-c
Longevity and cellular anti-aging	Longevity	Sermorelin + MOTS-c + NAD+
Maximizing TRT results	TRT Enhancement	Sermorelin + BPC-157 + Testosterone

The right stack depends on your specific goals, current health status, lab results, and medical history. Many patients start with one stack and evolve to others as their goals shift and their biology responds. This is not a decision to make based on internet research alone — it requires clinical evaluation and ongoing professional guidance.

Related Articles

• Peptides and Testosterone Stack: The Complete Guide
• What Is Peptide Therapy?
• Sermorelin vs Ipamorelin

See real patient results →

References

1. Teichman SL, Neale A, Lawrence B, et al. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab. 2006;91(3):799-805.
2. Sikiric P, Seiwerth S, Rucman R, et al. Brain-gut axis and pentadecapeptide BPC 157: theoretical and practical implications. Curr Neuropharmacol. 2016;14(8):857-865.
3. Falutz J, Allas S, Blot K, et al. Metabolic effects of a growth hormone-releasing factor in patients with HIV. N Engl J Med. 2007;357(23):2359-2370.
4. Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism. 2015;21(3):443-454.
5. Giannoulis MG, Sonksen PH, Umpleby M, et al. The effects of growth hormone and/or testosterone in healthy elderly men: a randomized controlled trial. J Clin Endocrinol Metab. 2006;91(2):477-484.

---

Ready to build your personalized peptide stack? Rewind Anti-Aging of Miami designs every peptide therapy protocol around your lab results, goals, and biology — not templates. Our process starts with comprehensive diagnostics and includes ongoing monitoring to optimize your results. Schedule a consultation →